Who Can Legally Operate
Today, only five vertically integrated pharmaceutical processors — one per each of Virginia's five health service regions — may legally cultivate, manufacture, and dispense cannabis commercially, and only to medical patients with practitioner certification. No adult-use cultivation, manufacturing, distribution, or retail license category currently exists in operation.
| Category | What You Can Do | Active Count (2026) |
|---|---|---|
| Pharmaceutical Processor | Vertically integrated: cultivate, process, and dispense medical cannabis products to certified patients | 5 permitted operators (AYR Virginia, Jushi Holdings, Green Thumb Industries, The Cannabist Company, Verano) |
| Cannabis Dispensing Facility | Retail dispensing location operated by/affiliated with a pharmaceutical processor | 23 dispensing facilities statewide |
| Adult-Use Cultivation / Processing / Retail / Wholesale / Microbusiness | Not currently authorized — would have been created by HB 642/SB 542 (vetoed May 19, 2026) | 0 — no licenses exist or have been issued |
The vetoed 2026 framework (HB 642/SB 542) proposed caps of 350 retail stores, 450 cultivation facilities, 60 processors, 25 wholesalers, and 100 microbusinesses, with existing pharmaceutical processors permitted to apply for "dual-use" adult-use privileges via a one-time conversion fee. None of these figures are currently in effect; they are included here only to show the shape of the framework most recently negotiated.
Virginia Cannabis Control Authority, Medical Cannabis Pharmaceutical Processors directory; Holon Law Partners, Virginia Adult Use Licensee Guide 2026; Virginia Mercury — Verified June 17, 2026.
License Application & Fees
Pharmaceutical processor permits are issued only during a defined Notice of Open Application (NOA) window and carry some of the steepest fixed fees of any state medical program, reflecting the small, capped number of vertically integrated operators.
| Fee | Amount | When Due |
|---|---|---|
| Application fee | $18,000 | At time of application during an open NOA window |
| Initial permit fee | $165,000 | Upon permit approval |
| Annual renewal fee | $132,000 | Annually thereafter |
| Adult-use "dual-use" conversion fee Not currently in effect | $5,000,000 (one-time, proposed) | Would have applied between Jul. 1–Nov. 1, 2026 under the now-vetoed framework, for existing processors to add adult-use privileges |
Virginia Cannabis Control Authority, Pharmaceutical Processors fee schedule; SB 542 / HB 642 conference text (vetoed) — Verified June 17, 2026.
Ownership & Operating Rules
Pharmaceutical processor permits are tightly held — one per health service region — and the CCA evaluates applicant suitability, financial backing, and operating plans. Because the adult-use commercial framework has not been enacted, no adult-use ownership caps, residency rules, or social-equity ownership set-asides are currently in force; the vetoed 2026 bill would have created "impact" applicant priority and equity ownership provisions (see Section 10).
| Requirement | Detail |
|---|---|
| Vertical integration | A single permit covers cultivation, processing, and dispensing — no standalone license tiers exist in the medical program |
| Geographic exclusivity | One processor permit per health service region (5 regions statewide) |
| Regulatory oversight transfer | CCA assumed all statutory and regulatory oversight from the Board of Pharmacy effective Jan. 1, 2024 |
| Product labeling | Recent legislation requires labels to disclose total mg of THC/CBD, mg per serving, and total THC/CBD percentage for inhalable products |
Virginia Cannabis Control Authority; Va. Code § 4.1-1602 — Verified June 17, 2026.
What You Can Legally Sell
Pharmaceutical processors may sell cannabis oils, flower, edibles, and other infused products to patients holding a valid practitioner certification. There is no licensed adult-use retail channel, so nothing may currently be sold to a consumer who is not a certified medical patient.
| Category | Status |
|---|---|
| Cannabis flower | Permitted for certified patients |
| Oils, tinctures, capsules | Permitted — original basis of the program (2015–2018) |
| Edibles & infused products | Permitted, subject to labeling requirements |
| Vaporizable concentrates | Permitted, subject to inhalable-product labeling rules (total THC/CBD %, mg per serving) |
| Adult-use retail products (any category, to non-patients) | Not legal — no licensed adult-use retail channel exists |
HB 75 (2026) allows hospital staff to possess and administer medical cannabis to certified patients in their care; nursing home and hospice staff have held similar authorization since 2021.
Virginia Cannabis Control Authority, medical cannabis product rules; Virginia Mercury, HB 75 reporting — Verified June 17, 2026.
Where You Can Legally Operate
Because no adult-use commercial framework is in effect, "where you can operate" today applies almost entirely to pharmaceutical processor siting and to home cultivation location rules — there is no adult-use retail siting question to answer yet.
| Activity | Rule |
|---|---|
| Pharmaceutical processor / dispensing facility siting | CCA permit plus local zoning approval; processors and dispensing facilities are distributed across Virginia's five health service regions |
| Home cultivation location | Limited to an adult's primary residence; plants must not be visible from a public space |
| Local opt-in/opt-out for any future adult-use retail | Not yet applicable — no enacted framework exists; the vetoed 2026 bill would have allowed localities to hold opt-out referenda, consistent with most other Eastern adult-use states |
Va. Code § 4.1-1101 (home cultivation); Virginia Cannabis Control Authority processor directory — Verified June 17, 2026.
What Customers & Patients Can Legally Do
Adults 21+ may legally possess and grow modest amounts of cannabis under the 2021 reenactment, even though there is nowhere licensed to buy it as an adult-use consumer. Medical patients with practitioner certification can purchase from one of 23 dispensing facilities statewide.
| Activity | Rule |
|---|---|
| Possession | Up to 1 ounce of marijuana |
| Home cultivation | Up to 4 plants per household at the cultivator's primary residence (not per person); plants must be tagged with the grower's name, driver's license/ID number, and notice that the marijuana is being grown for personal use, and kept out of public view |
| Sharing / gifting | Adults may give marijuana to another adult 21+ without remuneration, within possession limits; gifting marijuana as part of or in connection with another transaction (the "gray-market" gifting model used by some retailers) is illegal and prosecuted as unlicensed distribution |
| Public consumption | Prohibited |
| Medical patient purchasing | Requires written certification from a registered practitioner; Virginia discontinued its formal patient registry in July 2022, so patients no longer register with the state — exact current patient counts are not published, though a 2022 fiscal estimate put active patients near 40,000 and rising |
| Unlicensed retail purchase | There is no legal way to buy adult-use cannabis from a business in Virginia; purchasing from an unlicensed seller does not carry the same penalty as selling, but the seller is committing a criminal offense (see Section 11) |
Automatic sealing of many marijuana-related court and criminal history records begins July 1, 2026 under Virginia's new record-sealing chapter (Va. Code Title 19.2, Ch. 23.2) — eligible simple-possession and certain distribution records are sealed automatically without a petition. Petitions for sealing felony possession-with-intent-to-distribute records also become available starting the same date. Misdemeanor distribution convictions are eligible for automatic sealing after 7 years with no intervening convictions.
Va. Code § 4.1-1101; NORML, Virginia Marijuana Expungement Laws; Clean Slate Virginia, "New Virginia Laws in 2026: Criminal Record Sealing" — Verified June 17, 2026.
Tax Obligations
Because Virginia has no operating adult-use retail market, there is currently no cannabis excise tax of any kind in effect — only the state's standard 5.3% sales tax applies, and only to medical sales through pharmaceutical processors. The vetoed 2026 framework would have imposed a 6% (Gov. Spanberger's substitute proposed 8%) adult-use excise tax plus local option taxes, none of which exist today.
Separately, a federal DOJ/DEA final order moved marijuana sold under a qualifying state-licensed medical marijuana program from Schedule I to Schedule III, removing federal §280E for that revenue stream effective ~April 22–28, 2026 depending on source (this report series uses April 22, 2026 for cross-file consistency). Because Virginia's only operating commercial cannabis channel today is its medical pharmaceutical processor program, this rescheduling is unusually consequential here: Virginia's five processors should now be able to deduct ordinary business expenses beyond COGS on their federal returns for medical program revenue. Virginia conforms closely to federal taxable income for state corporate income tax purposes, so absent separate state guidance, this federal relief is expected to flow through to the processors' Virginia corporate income tax base as well — confirm current treatment with a cannabis-experienced CPA, as the Virginia Department of Taxation had not published cannabis-specific guidance on the rescheduling as of this report's publication.
| Tax / Fee | Rate | Paid By | Notes |
|---|---|---|---|
| State sales tax (medical) | 5.3% | Patient | Standard Virginia state sales tax rate applied to medical cannabis dispensed by pharmaceutical processors; no additional cannabis-specific excise tax currently exists |
| Adult-use excise tax | Not in effect Proposed: 6-8% | — | Would have applied under HB 642/SB 542, vetoed May 19, 2026; not currently chargeable on any transaction |
| Virginia corporate income tax | 6% | Cannabis business | Flat state corporate income tax rate; Virginia generally conforms to federal taxable income |
| Federal 280E — medical revenue | No longer applies Eff. ~Apr 22-28, 2026 | Cannabis business (federal) | Schedule III reclassification removes 280E for qualifying state medical program revenue/COGS — directly affects all 5 Virginia pharmaceutical processors, as this is currently their entire revenue base |
| Federal 280E — adult-use revenue | N/A — no adult-use revenue exists | — | Moot until/unless a licensed adult-use retail market is enacted; adult-use marijuana remains Schedule I federally |
SalesTaxHandbook, Virginia Marijuana Tax Handbook; Cannabis CPA Tax, Virginia Cannabis Tax Guide; Foley Hoag, Virginia adult-use bill reporting — Verified June 17, 2026.
Ongoing Compliance Obligations
Pharmaceutical processors operate under CCA-supervised compliance covering seed-to-sale tracking, testing, and labeling. There is no adult-use compliance regime to describe, since no adult-use licenses exist.
Virginia Cannabis Control Authority, Medical Cannabis Program Overview — Verified June 17, 2026.
Social Equity Compliance
Virginia's social equity framework exists only on paper today — codified in statute and built into the vetoed 2026 bill, but with no licenses, loans, or grants currently being issued because the adult-use program itself is not operating.
| Mechanism | Detail |
|---|---|
| Cannabis Equity Reinvestment Fund | Codified at Va. Code § 2.2-2499.8; would receive 30% of cannabis tax revenue under HB 642 to fund grants and technical assistance once a market exists |
| Cannabis Equity Business Loan Fund | Would receive 75% of marijuana establishment annual license fees (Jul. 1, 2026–Jul. 1, 2027 under the vetoed bill) to provide low-interest loans to equity applicants |
| "Impact" applicant priority | Would prioritize individuals with prior cannabis convictions, residents of historically impacted areas, and economically disadvantaged applicants in the first licensing window |
| Current operating status | None of the above is currently disbursing funds or issuing licenses — all are contingent on enactment of an adult-use retail framework |
Enforcement & Penalties
With no licensed adult-use retail channel, Virginia's enforcement priority is unlicensed commercial activity — particularly the "gifting" model some sellers use to disguise an underlying sale.
| Violation | Penalty |
|---|---|
| Possession over 1 oz (first offense) | Civil penalty; criminal penalties scale upward for repeat offenses and larger quantities |
| Distribution without a license (unlicensed sale) | Criminal offense under Va. Code § 18.2-248.1; penalties scale with quantity and intent, ranging from misdemeanor to felony |
| "Gifting" tied to another transaction | Prosecuted as unlicensed distribution notwithstanding the "gift" framing; the General Assembly has separately considered classifying this specifically as a Class 2 misdemeanor (Class 1 for repeat offenses), though this enhancement was tied to the vetoed bill and is not yet independently in force |
| Pharmaceutical processor compliance violations | CCA disciplinary action up to permit revocation |
Employment Law Intersections
Virginia gives medical cannabis patients specific drug-test protection and has recently issued guidance extending some protection to off-duty use generally, but employers otherwise retain broad testing authority.
| Permitted ✓ | Prohibited ✗ | Gray Area ⚠ |
|---|---|---|
| Employer drug testing of applicants and employees — Virginia has no general statute restricting employer testing programs | Discharging or disciplining a registered medical cannabis patient solely for a positive drug test, where there is no on-duty impairment | How state guidance on off-duty-use protection (recently published) interacts with an employer's existing zero-tolerance drug policy in practice |
| Disciplining any employee, patient or not, for on-duty impairment or use | — | — |
| — | Federal contractors/employers may still apply federal drug-free workplace rules regardless of state law | — |
Marijuana Moment, "Virginia Officials Publish Guidance On Marijuana Consumers' Workplace Rights"; VirginiaStateCannabis.org, Drug Testing Laws — Verified June 17, 2026.
Advertising & Marketing Rules
Advertising rules currently apply only to the medical pharmaceutical processor program; there is no adult-use advertising regime because there is no adult-use market.
| Permitted ✓ | Prohibited ✗ | Gray Area ⚠ |
|---|---|---|
| Informational advertising of pharmaceutical processor services to the general public, subject to CCA/Board of Pharmacy advertising standards | False or misleading claims about medical efficacy | Specific, codified content/placement restrictions (e.g., school-distance buffers, audience-composition thresholds) were not identified in current CCA guidance for the medical program — confirm directly with the CCA before launching a campaign |
| Patient education materials distributed through dispensing facilities | Marketing implying a product is suitable for non-certified adult-use consumers | — |
Virginia Cannabis Control Authority — note: detailed cannabis-specific advertising regulations were not located in current published CCA guidance; confirm directly with CCA before relying on this section for a campaign — Verified June 17, 2026.
Key Regulatory Resources & Contacts
Complete verified contact directory — direct CCA staff lines, Department of Taxation contacts, and pharmaceutical processor licensing support.
| Resource | URL | What It Covers |
|---|---|---|
| Virginia Cannabis Control Authority (CCA) | cca.virginia.gov | Medical pharmaceutical processor licensing, adult-use framework tracking |
| Va. Code Title 4.1, Ch. 6 & 16 | Code of Virginia | Statutory text governing possession, cultivation, and medical cannabis |
| Virginia Department of Taxation | tax.virginia.gov | Sales tax administration on medical cannabis sales |
| VA NORML — Legislation Tracker | vanorml.org | Session-by-session bill tracking, including the 2026 veto |
Recent Changes & What's Coming
Changed in the Last 24 Months
All statutory and regulatory oversight of the medical cannabis program transitioned from the Board of Pharmacy to the Virginia Cannabis Control Authority.
Gov. Spanberger vetoed the General Assembly's regulated adult-use retail framework — the third consecutive veto of an adult-use sales bill since 2022.
Allows hospital staff to possess and administer medical cannabis to certified patients, extending authority nursing home/hospice staff have held since 2021.
Automatic sealing of eligible marijuana possession and certain distribution records begins; felony PWID sealing petitions also become available.
State officials published guidance distinguishing off-duty, non-impairing cannabis use from on-duty impairment for employment purposes.
Watch List
With the May 2026 veto, renewed legislative negotiation over a regulated adult-use retail market is expected in the 2027 General Assembly session; the core dispute centers on tax rate, launch date, possession limits, and dispensary caps.
The $5 million one-time dual-use conversion fee for existing processors only becomes relevant if a future bill is enacted and signed.
Federal Watch
A DOJ/DEA final order moved marijuana sold under a qualifying state medical marijuana program from Schedule I to Schedule III, removing federal §280E for Virginia's medical pharmaceutical processor revenue — currently the entirety of the state's legal commercial cannabis revenue, making this unusually significant for Virginia specifically.
Cannabis banking access remains limited nationwide; Virginia's small processor base continues to rely on state-chartered, cannabis-friendly banking relationships.
Regulatory Calendar — Q3 2026
| Date / Period | Event | Relevant To |
|---|---|---|
| Jul 1, 2026 | Automatic record-sealing law takes effect; felony PWID sealing petitions become available | Individuals with eligible past cannabis convictions |
| Ongoing | CCA continues medical pharmaceutical processor compliance oversight; no adult-use rulemaking is active following the veto | 5 licensed processors, 23 dispensing facilities |
| 2027 Session | Earliest realistic window for renewed adult-use retail legislation | Prospective adult-use license applicants |
| Sep 14, 2026 | This CannBus Legal Summary refreshes — updated with Q3 2026 developments | All CannBus members |
Virginia Mercury; VA NORML 2026 legislation tracker; Foley Hoag Cannabis & the Law blog — all verified June 17, 2026.
This summary is for informational purposes only and does not constitute legal advice. Laws and regulations change. Consult a licensed Virginia attorney before making business or compliance decisions. CannBus is not a law firm and does not provide legal, financial, tax, or investment advice. All figures and rules reflect information verified as of June 17, 2026. Primary regulatory authority: Virginia Cannabis Control Authority — cca.virginia.gov. Next scheduled refresh: September 14, 2026.